BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 8182937)

  • 21. A novel chemokine, macrophage inflammatory protein-related protein-2, inhibits colony formation of bone marrow myeloid progenitors.
    Youn BS; Jang IK; Broxmeyer HE; Cooper S; Jenkins NA; Gilbert DJ; Copeland NG; Elick TA; Fraser MJ; Kwon BS
    J Immunol; 1995 Sep; 155(5):2661-7. PubMed ID: 7650394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors.
    Estrov Z; Kurzrock R; Estey E; Wetzler M; Ferrajoli A; Harris D; Blake M; Gutterman JU; Talpaz M
    Blood; 1992 Apr; 79(8):1938-45. PubMed ID: 1373331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The growth response of Lin-Thy-1+ hematopoietic progenitors to cytokines is determined by the balance between synergy of multiple stimulators and negative cooperation of multiple inhibitors.
    Jacobsen SE; Ruscetti FW; Ortiz M; Gooya JM; Keller JR
    Exp Hematol; 1994 Sep; 22(10):985-9. PubMed ID: 7522186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1 alpha, an inhibitor of primitive normal hematopoietic cells.
    Eaves CJ; Cashman JD; Wolpe SD; Eaves AC
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):12015-9. PubMed ID: 8265663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct and overlapping direct effects of macrophage inflammatory protein-1 alpha and transforming growth factor beta on hematopoietic progenitor/stem cell growth.
    Keller JR; Bartelmez SH; Sitnicka E; Ruscetti FW; Ortiz M; Gooya JM; Jacobsen SE
    Blood; 1994 Oct; 84(7):2175-81. PubMed ID: 7919333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice.
    Broxmeyer HE; Cooper S; Hague N; Benninger L; Sarris A; Cornetta K; Vadhan-Raj S; Hendrie P; Mantel C
    Ann Hematol; 1995 Nov; 71(5):235-46. PubMed ID: 7492626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement by transforming growth factor-beta 1 (TGF-beta 1) of the proliferation of leukemic blast progenitors stimulated with IL-3.
    Suzuki T; Bessho M; Hirashima K; Tohda S; Nagata K; Morio T; Imai Y; Nara N
    J Cell Physiol; 1991 Sep; 148(3):396-403. PubMed ID: 1717497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic and antagonistic effects of recombinant human interleukin (IL) 3, IL-1 alpha, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell lines.
    Santoli D; Yang YC; Clark SC; Kreider BL; Caracciolo D; Rovera G
    J Immunol; 1987 Nov; 139(10):3348-54. PubMed ID: 3500218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of recombinant GM-CSF and recombinant G-CSF on colony formation of blast progenitors in acute myeloblastic leukemia.
    Motoji T; Takanashi M; Fuchinoue M; Masuda M; Oshimi K; Mizoguchi H
    Exp Hematol; 1989 Jan; 17(1):56-60. PubMed ID: 2783249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leptin in human acute myelogenous leukemia: studies of in vivo levels and in vitro effects on native functional leukemia blasts.
    Bruserud Ø; Huang TS; Glenjen N; Gjertsen BT; Foss B
    Haematologica; 2002 Jun; 87(6):584-95. PubMed ID: 12031914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
    Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
    Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of colony stimulating factor-(CSF) dependent growth of acute myeloid leukemia by tumor necrosis factor.
    Salem M; Delwel R; Touw I; Mahmoud LA; Elbasousy EM; Löwenberg B
    Leukemia; 1990 Jan; 4(1):37-43. PubMed ID: 1688638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of interleukin-13 on cytokine secretion by human acute myelogenous leukemia blasts.
    Bruserud O
    Leukemia; 1996 Sep; 10(9):1497-1503. PubMed ID: 8751469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemokine expression in human erythroid leukemia cell line AS-E2: macrophage inflammatory protein-3alpha/CCL20 is induced by inflammatory cytokines.
    Inoue Y; Tsushima H; Ando K; Sawayama Y; Sakai M; Yamasaki R; Matsuo E; Tsutsumi C; Imaizumi Y; Iwanaga M; Imanishi D; Taguchi J; Miyazaki Y; Tomonaga M
    Exp Hematol; 2006 Jan; 34(1):19-26. PubMed ID: 16413387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progenitor cells in the blood and marrow of patients with chronic phase chronic myeloid leukaemia respond differently to macrophage inflammatory protein-1 alpha.
    Nirsimloo N; Gordon MY
    Leuk Res; 1995 May; 19(5):319-23. PubMed ID: 7769832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergy of interleukin 3 and tumor necrosis factor alpha in stimulating clonal growth of acute myelogenous leukemia blasts is the result of induction of secondary hematopoietic cytokines by tumor necrosis factor alpha.
    Brach MA; Gruss HJ; Asano Y; de Vos S; Ludwig WD; Mertelsmann R; Herrmann F
    Cancer Res; 1992 Apr; 52(8):2197-201. PubMed ID: 1373106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.